Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology

Authors:

Abstract
Hidradenitis suppurativa (HS) is a painful chronic inflammatory skin disease which impacts quality of life substantially. Its prevalence is estimated to 0.7%.1 Various pathophysiological hypotheses exist, but no therapeutic consensus, making the management of HS patients complex.
Funding Information
  • Société Française de Dermatologie et de Pathologie Sexuellement Transmissible

This publication has 6 references indexed in Scilit: